Accumulating evidence from murine models has established that genetic ablation of CD4+ T cells confers protection against aneurysm development, mechanistically linked to attenuated interferon‐gamma (IFN‐γ) signalling pathways [25]. The gene discussed is CD4; the disease is aneurysm.